479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629019940716544 |
|---|---|
| author | Xin Zhang Jing Zhang Yang Chen Yi Yang Weiqiu Lan Baihong Liu W Frank An Chaoshe Guo |
| author_facet | Xin Zhang Jing Zhang Yang Chen Yi Yang Weiqiu Lan Baihong Liu W Frank An Chaoshe Guo |
| author_sort | Xin Zhang |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:48:26Z |
| format | Article |
| id | doaj.art-d77b9ab3a1b843deaa843ebae461c715 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:48:26Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-d77b9ab3a1b843deaa843ebae461c7152023-11-13T22:10:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0479479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical modelsXin Zhang0Jing Zhang1Yang Chen2Yi Yang3Weiqiu Lan4Baihong Liu5W Frank An6Chaoshe Guo7Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, ChinaBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, ChinaBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, ChinaBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, ChinaBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, ChinaBiocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China |
| spellingShingle | Xin Zhang Jing Zhang Yang Chen Yi Yang Weiqiu Lan Baihong Liu W Frank An Chaoshe Guo 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models Journal for ImmunoTherapy of Cancer |
| title | 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models |
| title_full | 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models |
| title_fullStr | 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models |
| title_full_unstemmed | 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models |
| title_short | 479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models |
| title_sort | 479 fc competent fully human anti tigit blocking monoclonal antibodies demonstrated potent anti tumor efficacy in preclinical models |
| work_keys_str_mv | AT xinzhang 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT jingzhang 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT yangchen 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT yiyang 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT weiqiulan 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT baihongliu 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT wfrankan 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels AT chaosheguo 479fccompetentfullyhumanantitigitblockingmonoclonalantibodiesdemonstratedpotentantitumorefficacyinpreclinicalmodels |